INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the gradual loss of motoneurons and corticospinal tract neurons. Although the cause of this disorder is unknown, recent studies have suggested that dysregulation of excitatory amino acid (EAA) receptors, particularly those of the N-methyl-D-aspartate (NMDA) subtype, may be a key factor leading to neuronal death in sporadic ALS (Krieger et al., 1993; Plaitakis, 1990) . In some ALS patients, elevated concentrations of EAAs have been found in cerebrospinal fluid (Rothstein et al., 1990) , and decreased contents of glutamate and aspartate have been reported in neural tissue at autopsy (Plaitakis, 1990 ). An increase in the concentration of an NMDA agonist in spinal cords of ALS patients might have two related effects: (i) it might be excitotoxic and lead ultimately to motoneuron death (Plaitakis, 1990) and/or (ii) it may induce an agonist-mediated decrease of NMDA receptor number by homologous regulation (Pasqualotto & Shaw, 1996) . In keeping with either of these interpretations, autoradiographic studies of EAA receptors have shown reductions in NMDA receptor binding in spinal cords of ALS patients (Allaoua et al., 1992; Krieger et al., 1993a) . In the latter study, reductions in [ 3 H]MK-801 binding of 30-40% were detected in both dorsal and ventral horns of spinal cords in ALS patients compared to controls. Although cell death may clearly account for some reduction in NMDA receptor number in ALS, experimental support for an effect of receptor regulation comes from our study using phorbol esters to activate protein kinase C (PKC)
